It is a synthetic peptide analogous to the receptors of the naturally occurring peptide called ghrelin (aka the GHS-R1a receptors)
Recent studies have revealed an obligatory role of gut microbiota in the production of trimethylamine- N -oxide (TMAO) from ingested LC in humans [4]
Subsequently, other drugs such as Novos Victoza (liraglutide, approved in 2010), AstraZenecas Bydureon (exenatide, 2012), GSKs Tanzeum (albiglutide, 2014), Lillys Trulicity (dulaglutide, 2014) and Novos Ozempic (semaglutide, 2017) and Rybelsus (oral semaglutide, 2019) were approved
Neurological disorders In conditions like Parkinsons and Alzheimers diseases, disruptions in cellular Ca 2+ regulating systems in the plasma membrane, ER, and mitochondria can manifest in synaptic dysfunction, decreased plasticity, and neuronal degeneration [286,287,288]